BOTOX ONE
LIVE

Serial Number

97115781

Owner

ALLERGAN, INC.

First Use Date

Jan 19, 2019

Filing Date

Nov 9, 2021

Add to watchlist:

No watchlists yet
View on USPTO

BOTOX ONE Trademark

Serial Number: 97115781 • Registration: 7243678

BOTOX ONE is a trademark filed by ALLERGAN, INC. on November 9, 2021. The trademark is classified under Class 36 (Insurance & Financial), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

ALLERGAN, INC. (1,040 trademarks)

IRVINE, CA 92715

Entity Type: 03

Trademark Details

Filing Date

November 9, 2021

Registration Date

December 12, 2023

First Use Anywhere

January 19, 2019

First Use in Commerce

January 19, 2019

Published for Opposition

October 4, 2022

Goods & Services

Medical advisory services regarding treatment payment plan reimbursement of a portion of a patient's out-of-pocket expenses, namely, providing financial administration of patient reimbursement programs; assistance to patients regarding treatment payment plan options, namely, financial administration of patient reimbursement programs; providing financial information about the administration of patient reimbursement programs designed to assist patients regarding medical treatment payment plan options

Providing business information about the administration of patient reimbursement programs designed to assist patients regarding medical treatment payment plan options; assistance to patients regarding treatment payment plan options, namely, business administration of patient reimbursement programs; providing a website via a global computer network featuring consumer information and comprehensive content being consumer product information in the fields of neurology, dermatology and urology; distribution of samples for trial purposes in the field of neurology, dermatology and urology; promoting healthcare professionals' awareness of the benefits of botulinum toxin and dissemination of advertisements and consumer product information relating to botulinum toxin via print, audio, video, digital, on-line medium, and electronic mail

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 12, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 12, 2023 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Nov 9, 2023 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Nov 8, 2023 CNPR
EXAMINER'S AMENDMENT ENTERED
Nov 8, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 8, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 8, 2023 GNEA
SU-EXAMINER'S AMENDMENT WRITTEN
Nov 8, 2023 SNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 1, 2023 GNRN
NON-FINAL ACTION E-MAILED
Nov 1, 2023 GNRT
SU - NON-FINAL ACTION - WRITTEN
Nov 1, 2023 CNRT
STATEMENT OF USE PROCESSING COMPLETE
May 16, 2023 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
May 10, 2023 AITU
USE AMENDMENT FILED
Apr 21, 2023 IUAF
TEAS STATEMENT OF USE RECEIVED
Apr 21, 2023 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 29, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 4, 2022 NPUB
PUBLISHED FOR OPPOSITION
Oct 4, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 14, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 1, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 30, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 29, 2022 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Aug 29, 2022 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Jun 7, 2022 GNFN
FINAL REFUSAL E-MAILED
Jun 7, 2022 GNFR
FINAL REFUSAL WRITTEN
Jun 7, 2022 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
May 16, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 16, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 16, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 29, 2021 GNRN
NON-FINAL ACTION E-MAILED
Nov 29, 2021 GNRT
NON-FINAL ACTION WRITTEN
Nov 29, 2021 CNRT
ASSIGNED TO EXAMINER
Nov 24, 2021 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Nov 18, 2021 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 17, 2021 NWOS